7QW9 image
Deposition Date 2022-01-25
Release Date 2022-09-07
Last Version Date 2024-07-17
Entry Detail
PDB ID:
7QW9
Keywords:
Title:
Cryo-EM structure of coxsackievirus A6 mature virion
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.68 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP1
Chain IDs:A
Chain Length:304
Number of Molecules:1
Biological Source:Coxsackievirus A6
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP2
Chain IDs:B
Chain Length:256
Number of Molecules:1
Biological Source:Coxsackievirus A6
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP3
Chain IDs:C
Chain Length:241
Number of Molecules:1
Biological Source:Coxsackievirus A6
Polymer Type:polypeptide(L)
Molecule:Capsid protein VP4
Chain IDs:D
Chain Length:68
Number of Molecules:1
Biological Source:Coxsackievirus A6
Primary Citation
Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virion.
Commun Biol 5 898 898 (2022)
PMID: 36056184 DOI: 10.1038/s42003-022-03863-2

Abstact

Coxsackievirus A6 (CV-A6) has recently overtaken enterovirus A71 and CV-A16 as the primary causative agent of hand, foot, and mouth disease worldwide. Virions of CV-A6 were not identified in previous structural studies, and it was speculated that the virus is unique among enteroviruses in using altered particles with expanded capsids to infect cells. In contrast, the virions of other enteroviruses are required for infection. Here we used cryo-electron microscopy (cryo-EM) to determine the structures of the CV-A6 virion, altered particle, and empty capsid. We show that the CV-A6 virion has features characteristic of virions of other enteroviruses, including a compact capsid, VP4 attached to the inner capsid surface, and fatty acid-like molecules occupying the hydrophobic pockets in VP1 subunits. Furthermore, we found that in a purified sample of CV-A6, the ratio of infectious units to virions is 1 to 500. Therefore, it is likely that virions of CV-A6 initiate infection, like those of other enteroviruses. Our results provide evidence that future vaccines against CV-A6 should target its virions instead of the antigenically distinct altered particles. Furthermore, the structure of the virion provides the basis for the rational development of capsid-binding inhibitors that block the genome release of CV-A6.

Legend

Protein

Chemical

Disease

Primary Citation of related structures